INVICTA DIAGNOSTIC LTD Share Price

NSE: INVICTA

S Cap

₹ 77.00

-₹0.70 (-0.9%)

Last updated 11 Aug, 2026, 12:55 IST

INVICTA DIAGNOSTIC LTD Share Price Today

As of 11 Aug 2026, INVICTA DIAGNOSTIC LTD share price is ₹77.00. The stock opened at ₹78.50, compared to its previous close of ₹77.70. During today's trading session, INVICTA DIAGNOSTIC LTD share price moved in the range of ₹75.00 to ₹78.50, with an average price of ₹76.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹58.10 and a high of ₹105.00. On the performance front, INVICTA DIAGNOSTIC LTD share price has increased by 11.59% over the last six months and is down 20.37% on a year-on-year basis.

₹75.00

0.90% down today

₹78.50

1D LOW

1D HIGH

Stock Performance

OutperformingBeat Nifty by 11.05 % in last 1 month

Shareholding Pattern

DIIDII decreased stake by 57.93%

Shareholding Pattern

FIIFII increased stake by 345.93%

INVICTA DIAGNOSTIC LTD Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹4,45,860-₹54,140 (-10.83%)

3 Year

₹4,85,498-₹14,502 (-2.90%)

5 Year

₹4,85,498-₹14,502 (-2.90%)

₹62.20₹93.20

Circuit Low

Circuit High

₹58.10₹105.00

52-Week Low

52-Week High

Circuit

₹62.20

₹93.20

52-week

₹58.10

₹105.00

About INVICTA DIAGNOSTIC LTD

ISIN

INE0XJ501010

Sector Market Cap

Invicta Diagnostic Limited is engaged in the diagnostic chain offering comprehensive radiology and pathology solutions. It offers a one-stop solution for pathology and radiology testing services such as imaging (including radiology), pathology/clinical laboratory and tele-radiology to customers under the brand name PC Diagnostics through its operational network, which consists of eight diagnostic centers and one centralized laboratory across Mumbai Metropolitan Region in the state of Maharashtra. Its test menu includes pathology tests ranging from basic biochemistry and clinical pathology which are performed at its own centers to cytogenetics and high-end molecular diagnostic tests which are outsourced to larger reference laboratories, and radiology tests ranging from basic echocardiograms, X-rays and ultrasounds to advanced radiology tests including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans and advanced positron emission tomography CT.

INVICTA DIAGNOSTIC LTD Financial Highlights

Revenue: INVICTA DIAGNOSTIC LTD reported revenue of ₹33.04 crore in FY26 vs ₹30.19 crore in FY25. It showed an increase of 9.44% on a yearly basis.
Operating Profit: INVICTA DIAGNOSTIC LTD reported an operating profit of ₹7.01 crore in FY26 vs ₹6.56 crore in FY25. It showed an increase of 6.86% on a year-on-year basis.
Net Profit: INVICTA DIAGNOSTIC LTD reported a net profit of ₹4.87 crore in FY26 vs ₹4.93 crore in FY25. It showed a decrease of 1.22% on a yearly basis.

Know more

Promoters

66.70%

FII

4.20%

Other DII

4.30%

Retail and other

24.81%

Mutual funds

0.00%

Foreign institutions - FII

FII shareholding by period
Aug 2024	0.00%
Nov 2025	0.00%
Dec 2025	0.94%
Mar 2026	4.20%

Mkt Cap Cr

0.00

P/E

17.66

P/B

1.99

ROE

11.26%

D/E

0.00

ROCE

14.86%

Div. Yield

0.00%

EPS(TTM)

5.56

Turnover

0.41

EV/EBITDA

—

Net Margin

0.00%

Op. Margin

0.00%

ROA

—

Quick Ratio

0.00

Curr. Ratio

9.61

Mkt Cap Cr

0.00

P/E

17.66

P/B

1.99

ROE

11.26%

D/E

0.00

ROCE

14.86%

Div. Yield

0.00%

EPS(TTM)

5.56

Turnover

0.41

EV/EBITDA

—

Net Margin

0.00%

Op. Margin

0.00%

ROA

—

Quick Ratio

0.00

Curr. Ratio

9.61

Based on fundamentals, this stock's

Performance

Excellent

Invicta Diagnos. outperforming all market indices

Valuation

Fairly Valued

Invicta Diagnos. appears to be fairly valued compared to its peers

Earnings

Neutral

Invicta Diagnos. earnings growth is positive

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Apollo Hospitals	1,28,270.00	55.01	11.27	22.64%	0.34	18.12%	10.72	0.27%	0.70	103.81
Max Healthcare	1,04,137.00	64.89	8.71	14.33%	0.08	13.72%	10.47	0.21%	0.28	7.37
MANIPAL HEALTH ENTERPRI L	0.00	0.00	0.00	12.84%	0.46	12.07%	0.00	0.00%	0.00	0.00
Aster DM Healthcare	75,744.00	208.88	16.53	8.48%	0.31	10.10%	53.53	0.21%	0.43	5.20
Fortis Healthcare	72,098.50	67.35	7.29	10.53%	0.23	12.56%	122.24	0.10%	0.15	3.05
Global Health	39,680.10	71.85	10.02	14.05%	0.06	15.26%	149.24	0.03%	0.73	18.46
Narayana Hrudayalaya	37,494.10	45.91	8.26	17.76%	0.76	11.42%	127.10	0.25%	0.76	24.77
KRISHNA INST OF MED SCI L	34,413.20	176.97	9.18	10.74%	0.63	7.99%	93.54	0.00%	0.42	6.52
Dr. Lal Path Labs	32,761.40	59.97	13.06	20.13%	0.08	25.56%	147.52	1.05%	0.91	30.45
DR AGARWALS HEALTH CARE L	17,818.50	96.24	8.80	6.58%	0.34	9.75%	62.81	0.00%	0.46	1.25

INVICTA DIAGNOSTIC LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024
Revenue	₹30.10	₹7.99
Other Income	₹0.57	₹0.35
Total Revenue	₹30.66	₹8.34
Total Expenses	₹23.80	₹5.65
Profit Before Tax	₹6.86	₹2.69
Tax	₹2.17	₹0.00
Profit After Tax	₹4.69	₹2.69
EPS - Basic	₹5.57	₹3.19
EPS - Diluted	₹5.57	₹3.19

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024
Profit before tax	₹6.86	₹2.69
Income before WC changes	₹9.58	₹4.34
Change in Assets	-₹0.75	-₹1.26
Change in Liabilities	-₹1.26	₹2.24
Change in WC	-₹2.01	₹0.98
Cash flow from Operations	₹6.47	₹4.21
Cash flow from Investing	-₹5.23	-₹10.01
Cash flow from Financing	-₹0.42	₹7.14
Total Cash Flow	₹0.83	₹1.34
Cash (Start of the year)	₹1.34	₹0.00
Cash (End of the year)	₹2.16	₹1.34

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024
Non-Current Assets	₹14.87	₹12.13
Current Assets	₹6.38	₹3.71
Total Assets	₹21.25	₹15.84
Current Liabilities	₹2.44	₹2.24
Net Current Asset	₹3.94	₹1.47
Non-Current Liabilities	₹2.97	₹2.45
Equity Capital	₹15.84	₹11.14
Total Equity & Liabilities	₹21.25	₹15.84

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024
Revenue	₹16.27	₹3.50
Other Income	₹1.46	₹1.34
Total Revenue	₹17.73	₹4.84
Total Expenses	₹10.87	₹2.41
Profit Before Tax	₹6.86	₹2.42
Tax	₹1.48	₹0.02
Profit After Tax	₹5.38	₹2.40
EPS - Basic	₹6.39	₹182.49
EPS - Diluted	₹6.39	₹182.49

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024
Profit before tax	₹6.86	₹2.42
Income before WC changes	₹7.82	₹5.05
Change in Assets	-₹3.26	-₹1.00
Change in Liabilities	₹1.06	₹1.04
Change in WC	-₹2.20	₹0.04
Cash flow from Operations	₹4.13	₹5.05
Cash flow from Investing	-₹4.22	-₹9.51
Cash flow from Financing	₹0.00	₹5.35
Total Cash Flow	-₹0.08	₹0.89
Cash (Start of the year)	₹0.00	₹0.00
Cash (End of the year)	-₹0.08	₹0.89

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024
Non-Current Assets	₹12.40	₹9.13
Current Assets	₹5.10	₹1.92
Total Assets	₹17.50	₹11.06
Current Liabilities	₹2.12	₹1.04
Net Current Asset	₹2.98	₹0.88
Non-Current Liabilities	₹0.57	₹0.59
Equity Capital	₹14.81	₹9.43
Total Equity & Liabilities	₹17.50	₹11.06